Literature DB >> 2051890

Lipid and fatty acid composition is altered in plaque tissue from multiple sclerosis brain compared with normal brain white matter.

R Wilson1, D R Tocher.   

Abstract

Plaques and white matter from brains of multiple sclerosis (MS) patients were analyzed for lipid content, class composition, and fatty acid composition of total lipid, together with the fatty acid composition of plaque glycerophospholipids, and the results were compared with white matter from normal brain. Plaques contained less than 30% of the lipid present in normal white matter. Plaque lipid was characterized by significantly increased proportions of glycerophospholipids and decreased cerebrosides and sulfatides. In addition, a subacute plaque contained approximately 10 times the proportion of steryl esters observed in chronic plaques or normal white matter. Total lipid from all the MS plaques showed significantly increased percentages of saturated fatty acids, n-6, n-3 and total polyunsaturated fatty acids and decreased percentages of monoenes and alk-l-enyl ethers in comparison with normal brains. These results were consistent with increased cellularity and astrogliosis associated with MS plaques. However, analysis of plaque glycerophospholipids showed that the fatty acid changes observed in total lipid were not simply due to the increased proportion of glycerophospholipids and decreased myelin lipids, but that the fatty acid composition of the individual glycerophospholipids was different.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2051890     DOI: 10.1007/bf02544017

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  33 in total

1.  Serum linoleic acid in multiple sclerosis.

Authors:  F Wolfgram; L Myers; G Ellison; W Knipprath
Journal:  Neurology       Date:  1975-08       Impact factor: 9.910

2.  Lipids and multiple sclerosis.

Authors:  D Bates
Journal:  Biochem Soc Trans       Date:  1989-04       Impact factor: 5.407

3.  Myelin constituents of human central nervous system.

Authors:  J Clausen; I B Hansen
Journal:  Acta Neurol Scand       Date:  1970       Impact factor: 3.209

4.  Cerebral lipids in a case with a clinically silent isolated plaque of the multiple sclerosis type.

Authors:  M Wender; Z Adamczewska; A Wajgt
Journal:  Eur Neurol       Date:  1973       Impact factor: 1.710

5.  Major plasma lipids and their fatty acid composition in multiple sclerosis and other neurological diseases.

Authors:  I Karlsson; C Alling; L Svennerholm
Journal:  Acta Neurol Scand       Date:  1971       Impact factor: 3.209

6.  Multiple sclerosis.

Authors:  G M McKhann
Journal:  Annu Rev Neurosci       Date:  1982       Impact factor: 12.449

7.  Multiple sclerosis: a serial study using MRI in relapsing patients.

Authors:  C Isaac; D K Li; M Genton; C Jardine; E Grochowski; M Palmer; L F Kastrukoff; J Oger; D W Paty
Journal:  Neurology       Date:  1988-10       Impact factor: 9.910

8.  Essential fatty acids in the serum and cerebrospinal fluid of multiple sclerosis patients.

Authors:  I S Neu
Journal:  Acta Neurol Scand       Date:  1983-03       Impact factor: 3.209

9.  Fatty acid composition of phospholipids and neutral lipids during embryonic and early larval development in Atlantic herring (Clupea harengus, L.).

Authors:  D R Tocher; A J Fraser; J R Sargent; J C Gamble
Journal:  Lipids       Date:  1985-02       Impact factor: 1.880

10.  Lipid studies in the blood and brain in multiple sclerosis and motor neurone disease.

Authors:  J N Cumings; R C Shortman; T Skrbic
Journal:  J Clin Pathol       Date:  1965-09       Impact factor: 3.411

View more
  14 in total

1.  Monounsaturated fatty acids in blood cell membranes from patients with multiple sclerosis.

Authors:  Gloudina Maria Hon; Mogamat Shafick Hassan; Susan Janse van Rensburg; Stefan Abel; Rajiv T Erasmus; Tandi Matsha
Journal:  Inflammation       Date:  2011-12       Impact factor: 4.092

2.  Characterization of phospholipid methylation in rat brain myelin.

Authors:  V Tsvetnitsky; L Auchi; A Nicolaou; W A Gibbons
Journal:  Biochem J       Date:  1995-04-01       Impact factor: 3.857

3.  Abnormal fatty acid pattern in the superior temporal gyrus distinguishes bipolar disorder from major depression and schizophrenia and resembles multiple sclerosis.

Authors:  Robert K McNamara; Therese Rider; Ronald Jandacek; Patrick Tso
Journal:  Psychiatry Res       Date:  2014-01-02       Impact factor: 3.222

4.  The lipid composition of selected tissues from a Mediterranean monk seal, Monachus monachus.

Authors:  R J Henderson; N Kalogeropoulos; M N Alexis
Journal:  Lipids       Date:  1994-08       Impact factor: 1.880

5.  Molecular species composition of glycerophospholipids from white matter of human brain.

Authors:  R Wilson; M V Bell
Journal:  Lipids       Date:  1993-01       Impact factor: 1.880

6.  Oxidative Stress and Lymphocyte Alterations in Chronic Relapsing Experimental Allergic Encephalomyelitis in the Rat Hippocampus and Protective Effects of an Ethanolamine Phosphate Salt.

Authors:  Aranzazu Perianes-Cachero; María V T Lobo; Alberto M Hernández-Pinto; Rebeca Busto; Miguel Angel Lasunción-Ripa; Eduardo Arilla-Ferreiro; Lilian Puebla-Jiménez
Journal:  Mol Neurobiol       Date:  2019-09-10       Impact factor: 5.590

7.  Red blood cell membrane fluidity in the etiology of multiple sclerosis.

Authors:  Gloudina M Hon; Mogamat S Hassan; Susan J van Rensburg; Stefan Abel; Paul van Jaarsveld; Rajiv T Erasmus; Tandi Matsha
Journal:  J Membr Biol       Date:  2009-11-14       Impact factor: 1.843

8.  The enrichment of n-3 polyunsaturated fatty acids using aminopropyl solid phase extraction columns.

Authors:  R Wilson; R James Henderson; I C Burkow; J R Sargent
Journal:  Lipids       Date:  1993-01       Impact factor: 1.880

9.  1-O-alk-1'-enyl-2-acyl-glycerophosphoethanolamine content and molecular species composition in fish brain.

Authors:  M V Bell; J R Dick
Journal:  Lipids       Date:  1993-01       Impact factor: 1.880

Review 10.  Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis.

Authors:  Lahar R Mehta; Robert H Dworkin; Steven R Schwid
Journal:  Nat Clin Pract Neurol       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.